ProCE Banner Activity

Viral Hepatitis Update: CCO Independent Conference Coverage of EASL 2023

Podcast Episodes

Listen to expert insights from Stefan Zeuzem, MD, on viral hepatitis updates and new data from EASL 2023, including studies on HBV cure, HDV clinical trial and guideline updates, and HCV implementation science.

Released: July 11, 2023

Share

Faculty

Tatyana Kushner

Tatyana Kushner, MD, MSCE

Associate Professor
Division of Liver Diseases
Icahn School of Medicine at Mount Sinai
New York, New York

Heiner Wedemeyer

Heiner Wedemeyer, MD

Professor and Chairman
Department of Gastroenterology, Hepatology and Endocrinology
Hannover Medical School
Hannover, Germany

Stefan Zeuzem

Stefan Zeuzem, MD

Professor of Medicine
Chief, Department of Medicine
JW Goethe University Hospital
Frankfurt, Germany

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Tatyana Kushner, MD, MSCE

Associate Professor
Division of Liver Diseases
Icahn School of Medicine at Mount Sinai
New York, New York

Tatyana Kushner, MD, MSCE: advisor: AbbVie, Bausch, Gilead; researcher: Gilead.

Heiner Wedemeyer, MD

Professor and Chairman
Department of Gastroenterology, Hepatology and Endocrinology
Hannover Medical School
Hannover, Germany

Heiner Wedemeyer, MD: consultant/advisor/speaker: Falk, Gilead, GlaxoSmithKline, Janssen, Merck Sharp and Dohme, Roche, Vir Pharmaceuticals; researcher: Biotest.

Stefan Zeuzem, MD

Professor of Medicine
Chief, Department of Medicine
JW Goethe University Hospital
Frankfurt, Germany

Stefan Zeuzem, MD: consultant/advisor/speaker: AbbVie, BioMarin, Gilead Sciences, GlaxoSmithKline, Intercept, Janssen, MSD/Merck, Novo Nordisk, SoBi.